28. Local experience at DGH shows Combination Pertuzumab and Herceptin Nearly Doubles PCR Rate of Neo-adjuvant Chemotherapy (NAC) in HER2 Positive Breast Cancer. Issue 11 (November 2018) - Lake, Blossom; Appleton, Donna; Zachariah, Abel; Khan, Habib; Flemming, Kerry; Neill, Jennifer; Pettit, Laura